Interstitial Lung Disease Associated with Trastuzumab Deruxtecan in HER2D Metastatic Breast Cancer: a Real-world Experience

被引：0
|
作者：
Shaheen, A. [1 ]
Hayhurst, H. [1 ]
Omokhodion, O. [1 ]
Ayyad, A. [1 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 04期
关键词：
EMTANSINE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E111 / E112
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+Metastatic Breast Cancer: The DE-REAL Study
    Botticelli, Andrea
    Caputo, Roberta
    Scagnoli, Simone
    Pisegna, Simona
    De Laurentiis, Michelino
    Curigliano, Giuseppe
    Lambertini, Matteo
    Pantano, Francesco
    Palazzo, Antonella
    Paris, Ida
    Vernieri, Claudio
    Tedesco, Beatrice
    Giampaglia, Marianna
    Palleschi, Michela
    Ballatore, Zelmira
    Alesini, Daniele
    D'Auria, Giuliana
    Fabbri, Agnese
    Rossi, Luigi
    Verrazzo, Annarita
    Scafetta, Roberta
    Marinelli, Daniele
    Sposetti, Caterina
    Barberi, Vittoria
    Strigari, Lidia
    Marchetti, Paolo
    Santini, Daniele
    Fabi, Alessandra
    ONCOLOGIST, 2024, 29 (04): : 303 - 310
  • [2] Real world experience of trastuzumab deruxtecan for the treatment of metastatic breast cancer in the UK
    Cheng, Andy
    Frank, Suzanne
    Baines, Katherine
    Nathan, Mark
    Douglas, Rosalie V.
    Sylva, Rushan
    Ball, Jessica
    Savva, Constantinos
    Talbot, Thomas
    Oikonomidou, Olga
    Smith, Jenny
    Thomson, Alastair
    Ross, Felicity
    Konstantis, Apostolos
    Ainsworth, Nicola
    Luciano, Pietro
    Iyer, Pooja
    Acharige, Shyamika
    Rana, Shaikh
    King, Judy
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2-Expressing Metastatic Breast Cancer
    Rugo, Hope S.
    Crossno, Christine L.
    Gesthalter, Yaron B.
    Kelley, Kristen
    Moore, Heather B.
    Rimawi, Mothaffar F.
    Westbrook, Kelly E.
    Buys, Saundra S.
    JCO ONCOLOGY PRACTICE, 2023, 19 (08) : 539 - +
  • [4] Treatment rechallenge after grade 1 trastuzumab-deruxtecan related interstitial lung disease: A real-world experience
    Natsuhara, K. H.
    Vella, M.
    Behr, S. C.
    Quintal, L.
    Chien, J.
    Melisko, M. E.
    Majure, M.
    Buckle, G. C.
    Ko, A. H.
    Rugo, H. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S378 - S378
  • [5] Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
    Bahceci, Aykut
    Paydas, Semra
    Ak, Naziye
    Ferhatoglu, Ferhat
    Saip, Pinar Mualla
    Seydaoglu, Gulsah
    Bilici, Mehmet
    Simsek, Melih
    Tekin, Salim Basol
    Calikusu, Zuleyha
    Yavuz, Sinan
    Sahin, Ahmet Bilgehan
    Cubukcu, Erdem
    Evrensel, Turkkan
    Degirmencioglu, Serkan
    Demiray, Atike Gokcen
    Yumuk, Perran Fulden
    Alan, Ozkan
    Cikman, Duygu Ilke
    Demirelli, Fuat Hulusi
    Kostek, Osman
    Gokyer, Ali
    Dogan, Mutlu
    Bal, Oznur
    Cakar, Burcu
    Gokmen, Erhan
    Yamac, Deniz
    Korkmaz, Taner
    Aliyev, Altay
    Keskin, Ozge
    Urvay, Semiha
    Buyuksimsek, Mahmut
    Karadeniz, Cemile
    Yildiz, Birol
    Cinkir, Havva Yesil
    Demir, Hacer
    Beypinar, Ismail
    Karacin, Cengiz
    Eser, Kadir
    Baykara, Meltem
    Kilickap, Saadettin
    Okutur, Kerem
    Bulut, Gulcan
    Alkan, Ali
    Arpaci, Erkan
    Pilanci, Kezban Nur
    Demir, Atakan
    Isik, Deniz
    Yildirim, Nilgun
    CANCER INVESTIGATION, 2021, 39 (6-7) : 473 - 481
  • [6] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
  • [7] Real World Data for Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases
    Toler, Andrew
    Bobolts, Laura R.
    Mangurian, Mark
    Pozotrigo, Melissa
    Wise, Corey
    Solomon, Hiywete
    Hartung, Nicole
    Makielski, Rory
    Marur, Shika
    Ravindranathan, Meera
    Marur, Shanthi
    CANCER RESEARCH, 2023, 83 (05)
  • [8] Real world data on Trastuzumab Deruxtecan (T-DXd) induced Interstitial Lung disease (ILD) in HER2 positive metastatic breast cancer patients at the Kent Oncology Centre
    Mohammed, S.
    Moss, C.
    Harper-Wynne, C.
    CLINICAL ONCOLOGY, 2025, 38
  • [9] Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort Study
    Jourdain, Hugo
    Desplas, David
    Mansouri, Imene
    Zureik, Mahmoud
    Di Meglio, Antonio
    Haddy, Nadia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 531 - 531
  • [10] Trastuzumab deruxtecan-induced interstitial lung disease in a Filipino female patient with metastatic breast cancer
    Lim, Robyn Sy
    Alipio, Adrian Vincent Castro
    Tamayo, Maria Belen
    ANNALS OF ONCOLOGY, 2023, 34 : S1449 - S1449
12345